tiprankstipranks
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
US Market
Want to see BLCO full AI Analyst Report?

Bausch + Lomb Corporation (BLCO) Stock Forecast & Price Target

150 Followers
See the Price Targets and Ratings of:

BLCO Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
4 Buy
5 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Bausch
+ Lomb Corporation
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BLCO Stock 12 Month Forecast

Average Price Target

$19.75
▲(22.14% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Bausch + Lomb Corporation in the last 3 months. The average price target is $19.75 with a high forecast of $23.00 and a low forecast of $16.00. The average price target represents a 22.14% change from the last price of $16.17.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","15":"$15","18":"$18","21":"$21","24":"$24"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$23.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15,18,21,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.91,17.37846153846154,17.846923076923076,18.315384615384616,18.783846153846152,19.252307692307692,19.720769230769232,20.189230769230768,20.657692307692308,21.126153846153848,21.594615384615384,22.063076923076924,22.53153846153846,{"y":23,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.91,17.12846153846154,17.346923076923076,17.565384615384616,17.783846153846152,18.002307692307692,18.220769230769232,18.439230769230768,18.657692307692308,18.876153846153848,19.094615384615384,19.313076923076924,19.53153846153846,{"y":19.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.91,16.84,16.77,16.7,16.63,16.56,16.49,16.42,16.35,16.28,16.21,16.14,16.07,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.67,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.94,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.77,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.41,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.31,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.39,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.55,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.91,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$23.00Average Price Target$19.75Lowest Price Target$16.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on BLCO
H.C. Wainwright
H.C. Wainwright
$20$21
Buy
29.87%
Upside
Reiterated
08/03/26
Bausch + Lomb price target raised to $21 from $20 at H.C. WainwrightBausch + Lomb price target raised to $21 from $20 at H.C. Wainwright
Wells Fargo Analyst forecast on BLCO
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$18
Hold
11.32%
Upside
Reiterated
07/30/26
Wells Fargo Sticks to Their Hold Rating for Bausch + Lomb Corporation (BLCO)
Evercore ISI Analyst forecast on BLCO
Evercore ISI
Evercore ISI
$17
Hold
5.13%
Upside
Reiterated
07/30/26
Evercore ISI Remains a Hold on Bausch + Lomb Corporation (BLCO)
RBC Capital Analyst forecast on BLCO
RBC Capital
RBC Capital
$21
Buy
29.87%
Upside
Reiterated
07/30/26
RBC Capital Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Bank of America Securities Analyst forecast on BLCO
Bank of America Securities
Bank of America Securities
Sell
Reiterated
07/30/26
Analysts Conflicted on These Healthcare Names: Bausch + Lomb Corporation (NYSE: BLCO) and Pharming Group (NASDAQ: PHAR)
UBS
$21$23
Buy
42.24%
Upside
Initiated
07/30/26
Bausch + Lomb initiated with a Buy at UBSBausch + Lomb initiated with a Buy at UBS
Needham
Hold
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (NASDAQ: TNYA), Bausch + Lomb Corporation (NYSE: BLCO) and Curis (NASDAQ: CRIS)
Goldman Sachs Analyst forecast on BLCO
Goldman Sachs
Goldman Sachs
$21
Hold
29.87%
Upside
Reiterated
07/14/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch + Lomb Corporation (NYSE: BLCO) and Intellia Therapeutics (NASDAQ: NTLA)
Citi
$19$21
Buy
29.87%
Upside
Reiterated
07/08/26
Citi Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Stifel Nicolaus Analyst forecast on BLCO
Stifel Nicolaus
Stifel Nicolaus
$16
Hold
-1.05%
Downside
Reiterated
05/21/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus
Deutsche Bank  Analyst forecast on BLCO
Deutsche Bank
Deutsche Bank
$18$16
Hold
-1.05%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $18 at Deutsche BankBausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
Barclays Analyst forecast on BLCO
Barclays
Barclays
$20
Hold
23.69%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Align Tech (NASDAQ: ALGN) and Bausch + Lomb Corporation (NYSE: BLCO)
J.P. Morgan Analyst forecast on BLCO
J.P. Morgan
J.P. Morgan
$13$16
Hold
-1.05%
Downside
Reiterated
10/30/25
Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on BLCO
H.C. Wainwright
H.C. Wainwright
$20$21
Buy
29.87%
Upside
Reiterated
08/03/26
Bausch + Lomb price target raised to $21 from $20 at H.C. WainwrightBausch + Lomb price target raised to $21 from $20 at H.C. Wainwright
Wells Fargo Analyst forecast on BLCO
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$18
Hold
11.32%
Upside
Reiterated
07/30/26
Wells Fargo Sticks to Their Hold Rating for Bausch + Lomb Corporation (BLCO)
Evercore ISI Analyst forecast on BLCO
Evercore ISI
Evercore ISI
$17
Hold
5.13%
Upside
Reiterated
07/30/26
Evercore ISI Remains a Hold on Bausch + Lomb Corporation (BLCO)
RBC Capital Analyst forecast on BLCO
RBC Capital
RBC Capital
$21
Buy
29.87%
Upside
Reiterated
07/30/26
RBC Capital Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Bank of America Securities Analyst forecast on BLCO
Bank of America Securities
Bank of America Securities
Sell
Reiterated
07/30/26
Analysts Conflicted on These Healthcare Names: Bausch + Lomb Corporation (NYSE: BLCO) and Pharming Group (NASDAQ: PHAR)
UBS
$21$23
Buy
42.24%
Upside
Initiated
07/30/26
Bausch + Lomb initiated with a Buy at UBSBausch + Lomb initiated with a Buy at UBS
Needham
Hold
Reiterated
07/29/26
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (NASDAQ: TNYA), Bausch + Lomb Corporation (NYSE: BLCO) and Curis (NASDAQ: CRIS)
Goldman Sachs Analyst forecast on BLCO
Goldman Sachs
Goldman Sachs
$21
Hold
29.87%
Upside
Reiterated
07/14/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch + Lomb Corporation (NYSE: BLCO) and Intellia Therapeutics (NASDAQ: NTLA)
Citi
$19$21
Buy
29.87%
Upside
Reiterated
07/08/26
Citi Keeps Their Buy Rating on Bausch + Lomb Corporation (BLCO)
Stifel Nicolaus Analyst forecast on BLCO
Stifel Nicolaus
Stifel Nicolaus
$16
Hold
-1.05%
Downside
Reiterated
05/21/26
Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus
Deutsche Bank  Analyst forecast on BLCO
Deutsche Bank
Deutsche Bank
$18$16
Hold
-1.05%
Downside
Reiterated
04/30/26
Bausch + Lomb price target lowered to $16 from $18 at Deutsche BankBausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
Barclays Analyst forecast on BLCO
Barclays
Barclays
$20
Hold
23.69%
Upside
Reiterated
04/30/26
Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC), Align Tech (NASDAQ: ALGN) and Bausch + Lomb Corporation (NYSE: BLCO)
J.P. Morgan Analyst forecast on BLCO
J.P. Morgan
J.P. Morgan
$13$16
Hold
-1.05%
Downside
Reiterated
10/30/25
Bausch + Lomb price target raised to $16 from $13 at JPMorganBausch + Lomb price target raised to $16 from $13 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch + Lomb Corporation

3 Months
Douglas MiehmRBC Capital
Success Rate
17/29 ratings generated profit
59%
Average Return
+1.88%
Copying Douglas Miehm's trades and holding each position for 3 Months would result in 58.62% of your transactions generating a profit, with an average return of +1.88% per trade.
1 Year
Douglas MiehmRBC Capital
Success Rate
17/29 ratings generated profit
59%
Average Return
+4.08%
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 58.62% of your transactions generating a profit, with an average return of +4.08% per trade.
2 Years
Yi ChenH.C. Wainwright
Success Rate
8/14 ratings generated profit
57%
Average Return
+4.59%
Copying Yi Chen's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +4.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLCO Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
9
7
5
5
5
Hold
14
10
9
7
6
Sell
2
1
1
1
1
Strong Sell
0
0
0
0
0
total
25
18
15
13
12
In the current month, BLCO has received 5 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. BLCO average Analyst price target in the past 3 months is 19.75.
Each month's total comprises the sum of three months' worth of ratings.

BLCO Financial Forecast

BLCO Earnings Forecast

Next quarter’s earnings estimate for BLCO is $0.21 with a range of $0.17 to $0.25. The previous quarter’s EPS was $0.15. BLCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.
Next quarter’s earnings estimate for BLCO is $0.21 with a range of $0.17 to $0.25. The previous quarter’s EPS was $0.15. BLCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.32% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.

BLCO Sales Forecast

Next quarter’s sales forecast for BLCO is $1.37B with a range of $1.36B to $1.37B. The previous quarter’s sales results were $1.39B. BLCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.
Next quarter’s sales forecast for BLCO is $1.37B with a range of $1.36B to $1.37B. The previous quarter’s sales results were $1.39B. BLCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 31.16% of the time in the same period. In the last calendar year BLCO has Performed in-line its overall industry.

BLCO Stock Forecast FAQ

What is BLCO’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is 19.75.
    What is BLCO’s upside potential, based on the analysts’ average price target?
    Bausch + Lomb Corporation has 22.14% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is BLCO a Buy, Sell or Hold?
          Bausch + Lomb Corporation has a consensus rating of Moderate Buy which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Bausch + Lomb Corporation’s price target?
            The average price target for Bausch + Lomb Corporation is 19.75. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $23.00 ,the lowest forecast is $16.00. The average price target represents 22.14% Increase from the current price of $16.17.
              What do analysts say about Bausch + Lomb Corporation?
              Bausch + Lomb Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of BLCO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.